Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank58
3Y CAGR-64.9%
5Y CAGR-28.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-64.9%/yr
Annual compound
5Y CAGR
-28.7%/yr
Recent deceleration
Percentile
P58
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.15 | -37.7% |
| 2024 | 5.06 | -71.8% |
| 2023 | 17.91 | -75.4% |
| 2022 | 72.75 | +21.3% |
| 2021 | 59.96 | +249.6% |
| 2020 | 17.15 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |